Cleopatra Hospital Valuation Multiples

Cleopatra Hospital is valued at $346M as of November 2026, a 2.4x revenue multiple. In the last 12 months, Cleopatra Hospital revenue was $175M and Cleopatra Hospital EBITDA was $42M.

Cleopatra Hospital Overview

About Cleopatra Hospital

Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company’s segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.


Founded

1979

HQ

Egypt

Employees

4.4K

Financials (LTM)

Revenue: $175M
EBITDA: $42M

EV

$418M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cleopatra Hospital Financials

Cleopatra Hospital reported last 12-month revenue of $175M and EBITDA of $42M.

In the same LTM period, Cleopatra Hospital generated $68M in gross profit, $42M in EBITDA, and $16M in net income.


Cleopatra Hospital P&L

In the most recent fiscal year, Cleopatra Hospital reported revenue of $130M and EBITDA of $32M.

Cleopatra Hospital is profitable as of last fiscal year, with gross margin of 40%, EBITDA margin of 24%, and net margin of 11%.

See analyst estimates for Cleopatra Hospital
LTMLast FY2025202620272028
Revenue$175M$130M$130M
Gross Profit$68M$52M$52M
Gross Margin39%40%40%
EBITDA$42M$32M$32M
EBITDA Margin24%24%24%
EBIT Margin19%22%22%
Net Profit$16M$15M$15M
Net Margin9%11%11%
Net Debt-$55M-

Financial data powered by Morningstar, Inc.

Cleopatra Hospital Stock Performance

Cleopatra Hospital has current market cap of $346M, and enterprise value of $418M.

Market Cap Evolution


Cleopatra Hospital's stock price is $0.24.

Cleopatra Hospital has an EPS (earnings per share) of $0.01.

See more trading valuation data for Cleopatra Hospital
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$418M$346M2.2%---$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cleopatra Hospital Valuation Multiples

Cleopatra Hospital trades at 2.4x EV/Revenue multiple, and 10.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Cleopatra Hospital

Cleopatra Hospital Financial Valuation Multiples

As of November 4, 2026, Cleopatra Hospital has market cap of $346M and EV of $418M.

Cleopatra Hospital has a P/E ratio of 21.0x.

LTMLast FY2025202620272028
EV/Revenue2.4x3.2x3.2x
EV/EBITDA10.1x13.2x13.2x
EV/EBIT12.3x14.6x14.6x
EV/Gross Profit6.2x8.1x8.1x
P/E21.0x23.3x23.3x
EV/FCF-(24.4x)(24.4x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cleopatra Hospital Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cleopatra Hospital Margins & Growth Rates

Cleopatra Hospital grew revenue by 40% and EBITDA by 36% in the last fiscal year.

In the most recent fiscal year, Cleopatra Hospital reported gross margin of 40%, EBITDA margin of 24%, and net margin of 11%.

See estimated margins and future growth rates for Cleopatra Hospital

Cleopatra Hospital Margins

Last FY20252026202720282029
Gross Margin40%40%38%
EBITDA Margin24%24%24%
EBIT Margin22%22%19%
Net Margin11%11%9%
FCF Margin(13%)(13%)6%

Cleopatra Hospital Growth Rates

FY+1/FY25/2626/2727/2828/29
Revenue Growth40%40%
Gross Profit Growth36%36%
EBITDA Growth36%36%
EBIT Growth22%22%
Net Profit Growth13%13%
FCF Growth(164%)(164%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Cleopatra Hospital Operational KPIs

Cleopatra Hospital's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

Cleopatra Hospital's Rule of 40 is 64% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cleopatra Hospital's Rule of X is 123% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Cleopatra Hospital
LTMLast FY2025202620272028
Rule of 4049%64%-
Bessemer Rule of X86%123%-
Revenue per Employee-$0.0M-
Opex per Employee-$0.0M-
S&M Expenses to Revenue-2%2%
G&A Expenses to Revenue-3%3%
Opex to Revenue-18%18%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cleopatra Hospital Competitors

Cleopatra Hospital competitors include Auna, Humana, Indraprastha Medical Corp, M1 Kliniken, Strata Critical Medical, Hermina Hospitals, Community Health Systems, Clinica Las Condes, MediClin and Dr. Agarwal's Eye Hospital.

Most Cleopatra Hospital public comparables operate across Hospitals & Clinics.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Auna$1.3B$242M1.0x0.9x5.5x4.9x
Humana$1B$110M0.7x0.7x6.8x6.3x
Indraprastha Medical Corp$150M$28M1.9x1.8x10.2x9.6x
M1 Kliniken$408M$44M0.8x1.7x7.5x8.7x
Strata Critical Medical$197M($16M)1.8x1.3x(22.2x)11.8x
Hermina Hospitals$393M$102M1.7x1.6x6.4x6.1x
Community Health Systems$12B$2B0.9x0.9x5.4x8.5x
Clinica Las Condes$168M($78M)3.1x-(6.6x)-

This data is available for Pro users. Sign up to see all Cleopatra Hospital competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cleopatra Hospital

When was Cleopatra Hospital founded?Cleopatra Hospital was founded in 1979.
Where is Cleopatra Hospital headquartered?Cleopatra Hospital is headquartered in Egypt.
How many employees does Cleopatra Hospital have?As of today, Cleopatra Hospital has over 4K employees.
Is Cleopatra Hospital publicly listed?Yes, Cleopatra Hospital is a public company listed on Egyptian Exchange.
What is the stock symbol of Cleopatra Hospital?Cleopatra Hospital trades under CLHO ticker.
When did Cleopatra Hospital go public?Cleopatra Hospital went public in 2016.
Who are competitors of Cleopatra Hospital?Cleopatra Hospital main competitors include Auna, Humana, Indraprastha Medical Corp, M1 Kliniken, Strata Critical Medical, Hermina Hospitals, Community Health Systems, Clinica Las Condes, MediClin, Dr. Agarwal's Eye Hospital.
What is the current market cap of Cleopatra Hospital?Cleopatra Hospital's current market cap is $346M.
What is the current revenue of Cleopatra Hospital?Cleopatra Hospital's last 12 months revenue is $175M.
What is the current revenue growth of Cleopatra Hospital?Cleopatra Hospital revenue growth (NTM/LTM) is 25%.
What is the current EV/Revenue multiple of Cleopatra Hospital?Current revenue multiple of Cleopatra Hospital is 2.4x.
What is the current EBITDA of Cleopatra Hospital?Cleopatra Hospital's last 12 months EBITDA is $42M.
What is Cleopatra Hospital's EBITDA margin?Cleopatra Hospital's last 12 months EBITDA margin is 24%.
What is the current EV/EBITDA multiple of Cleopatra Hospital?Current EBITDA multiple of Cleopatra Hospital is 10.1x.
How many companies Cleopatra Hospital has acquired to date?Cleopatra Hospital hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cleopatra Hospital has invested to date?Cleopatra Hospital hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Cleopatra Hospital

Lists including Cleopatra Hospital

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial